Published in Cancer Invest on January 01, 1998
The Dartmouth Regimen: gone or going strong? Cancer Invest (1998) 0.76
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45
Extended use of nursing services in general practice. Br Med J (1967) 6.35
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
The practice nurse--a new look. Br Med J (1970) 5.16
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol (1991) 5.02
Ligand binding to integrins. J Biol Chem (2000) 4.94
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med (1984) 4.73
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol (2005) 3.62
The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell (1982) 3.38
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34
Reactions to tetanus toxoid. J Hyg (Lond) (1973) 3.33
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med (1999) 3.18
Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem (1998) 2.80
Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78
Local immune response in experimental pyelonephritis. J Clin Invest (1969) 2.73
Localization of urinary-tract infections by detection of antibody-coated bacteria in urine sediment. N Engl J Med (1974) 2.63
Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63
Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol (1996) 2.62
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Death in the AIDS patient: role of cytomegalovirus. N Engl J Med (1983) 2.61
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest (1995) 2.29
Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function. J Exp Med (1985) 2.27
RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24
Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun (1980) 2.22
General practitioners in hospital. Br Med J (1970) 2.22
New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21
Excess mortality associated with influenza in England and Wales. Int J Epidemiol (1977) 2.20
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med (1985) 2.18
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol (1994) 2.17
Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun (1997) 2.14
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med (1985) 2.14
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res (2001) 2.12
Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol (1983) 2.12
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol (1993) 2.08
Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest (1998) 2.06
Duration of immunity after active immunisation against tetanus. Lancet (1969) 2.04
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Radioimmunoassay for prostaglandins. Science (1971) 1.99
The development of erectile dysfunction in men treated for prostate cancer. J Urol (2001) 1.97
Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg (1998) 1.96
Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol (1977) 1.94
The influence of a competitor on the geographic mosaic of coevolution between crossbills and lodgepole pine. Evolution (2001) 1.93
Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc Natl Acad Sci U S A (1981) 1.90
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.86
Adeno-associated virus proteins: origin of the capsid components. J Virol (1984) 1.84
Mental neuropathy (numb chin syndrome). A harbinger of tumor progression or relapse. Cancer (1992) 1.81
Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J Biol Chem (1995) 1.80
Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis (1985) 1.78
Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones. J Immunol (1984) 1.75
Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol (2000) 1.74
THE CATEGORY OF TOPOLOGICAL OBJECTS. Proc Natl Acad Sci U S A (1961) 1.73
Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci U S A (1999) 1.72
Alcohol and other substance abuse and impairment among physicians in residency training. Ann Intern Med (1992) 1.72
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood (2001) 1.71
Prevention of tetanus in the wounded. Br Med J (1975) 1.71
HIV transmitted by sexual intercourse but not by kissing. Br Med J (Clin Res Ed) (1987) 1.70
Observations on the collagen and proteinpolysaccharide complex of rabbit cornea stroma. J Cell Sci (1969) 1.70
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol (1998) 1.70
Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol (1996) 1.70
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
Peripheral clonal elimination of functional T cells. Science (1990) 1.69
p53 mutation is associated with progression in follicular lymphomas. Blood (1993) 1.69
Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. Cell Growth Differ (1994) 1.68
Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68
Comparative study of district and community hospitals. Br Med J (1973) 1.67
Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy. Blood (1992) 1.66
Integrin-mediated cell adhesion: the extracellular face. J Biol Chem (1994) 1.66
Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med (1981) 1.65
Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1988) 1.64
Growth and toxin production of Tetanus bacilli in vivo. J Med Microbiol (1974) 1.63
Clonal analysis of the major histocompatibility complex restriction and the fine specificity of antigen recognition in the T cell proliferative response to cytochrome C. J Immunol (1983) 1.63
The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones. J Immunol (1983) 1.61
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. J Natl Cancer Inst (1999) 1.61
Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol (1990) 1.61
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest (1998) 1.61
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis (1997) 1.60
Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem (1994) 1.60
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia. Nature (1984) 1.58